1. Home
  2. FLNC vs NVCR Comparison

FLNC vs NVCR Comparison

Compare FLNC & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fluence Energy Inc.

FLNC

Fluence Energy Inc.

HOLD

Current Price

$13.77

Market Cap

2.2B

Sector

Miscellaneous

ML Signal

HOLD

Logo NovoCure Limited

NVCR

NovoCure Limited

HOLD

Current Price

$10.91

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FLNC
NVCR
Founded
2018
2000
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Medical/Dental Instruments
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
1.5B
IPO Year
2021
2015

Fundamental Metrics

Financial Performance
Metric
FLNC
NVCR
Price
$13.77
$10.91
Analyst Decision
Hold
Buy
Analyst Count
18
6
Target Price
$16.93
$28.08
AVG Volume (30 Days)
3.5M
1.2M
Earning Date
05-06-2026
04-23-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
21.79
EPS
N/A
N/A
Revenue
$2,262,830,000.00
$655,353,000.00
Revenue This Year
$51.18
$7.72
Revenue Next Year
$21.37
$6.74
P/E Ratio
N/A
N/A
Revenue Growth
N/A
8.28
52 Week Low
$3.46
$9.82
52 Week High
$33.51
$20.05

Technical Indicators

Market Signals
Indicator
FLNC
NVCR
Relative Strength Index (RSI) 36.55 40.06
Support Level $7.02 N/A
Resistance Level $18.21 $13.59
Average True Range (ATR) 0.99 0.58
MACD -0.06 -0.18
Stochastic Oscillator 19.14 23.02

Price Performance

Historical Comparison
FLNC
NVCR

About FLNC Fluence Energy Inc.

Fluence Energy Inc provides intelligent energy storage and optimization software for renewables and storage. Its energy storage solutions and operational services support a more resilient grid and help unlock the potential of renewable portfolios. The company's offerings include energy storage solutions, recurring operational and maintenance services, and Software-as-a-Service (SaaS) products designed to meet customer business needs, performance requirements, in-house capabilities, and risk profiles. Its service plans offer varying levels of training, maintenance, guarantees, warranties, and support for active system management. The company operates in the Americas, APAC and EMEA, with the majority of revenue coming from the Americas.

About NVCR NovoCure Limited

NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.

Share on Social Networks: